Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic ExperienceR.S. Bhangoo, Terence T. Sio, Dawn E. Jaroszewski et al.|Advances in Radiation Oncology|2020Cited by 31
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical ExperienceR.S. Bhangoo, Christopher L. Hallemeier, Trey C. Mullikin et al.|Advances in Radiation Oncology|2021Cited by 26
HPV16 L1 Capsid Antibody Titers and Prognosis in HPV Associated Malignancy: Oropharyngeal, Anal, Cervical and Vaginal CancerDavid M. Routman, Krishan R. Jethwa, Allison E. Garda et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 1
Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation TherapyIsabella Zaniletti, T.A. DeWees, Heather Gunn et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 1
Acute Toxicities and Short-Term Follow-up of 31 Patients Treated with Intensity-Modulated Proton Beam Radiotherapy (IMPT) for Unresectable Hepatocellular Carcinoma (HCC): A Single-Institution, Two Campus ExperienceR.S. Bhangoo, Terence T. Sio, Trey C. Mullikin et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 0